TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Inro Biomedtek AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
482
|
398 | |
| Financial expenses |
1,236
|
7,802 | |
| Earnings before taxes |
-568
|
-7,375 | |
| EBITDA |
384
|
315 | |
| Total assets |
13,550
|
14,619 | |
| Current assets |
13,408
|
14,422 | |
| Current liabilities |
943
|
1,309 | |
| Equity capital |
12,607
|
13,310 | |
| - share capital |
100
|
100 | |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
93.0%
|
91.0% | |
| Turnover per employee |
482
|
398 | |
| Profit as a percentage of turnover |
-117.8%
|
-1853.0% | |
| Return on assets (ROA) |
4.9%
|
2.9% | |
| Current ratio |
1421.8%
|
1101.8% | |
| Return on equity (ROE) |
-4.5%
|
-55.4% | |
| Change turnover |
84
|
30 | |
| Change turnover % |
-10%
|
21%
|
8% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.